These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2972813)

  • 1. Systemic lipopolysaccharide and pokeweed mitogen increase quinolinic acid content of mouse cerebral cortex.
    Heyes MP; Kim P; Markey SP
    J Neurochem; 1988 Dec; 51(6):1946-8. PubMed ID: 2972813
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systemic endotoxin increases L-tryptophan, 5-hydroxyindoleacetic acid, 3-hydroxykynurenine and quinolinic acid content of mouse cerebral cortex.
    Heyes MP; Quearry BJ; Markey SP
    Brain Res; 1989 Jul; 491(1):173-9. PubMed ID: 2475209
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of immune activation on quinolinic acid and neuroactive kynurenines in the mouse.
    Saito K; Markey SP; Heyes MP
    Neuroscience; 1992 Nov; 51(1):25-39. PubMed ID: 1465184
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain and plasma quinolinic acid in profound insulin-induced hypoglycemia.
    Heyes MP; Papagapiou M; Leonard C; Markey SP; Auer RN
    J Neurochem; 1990 Mar; 54(3):1027-33. PubMed ID: 1689373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantification of quinolinic acid in rat brain, whole blood, and plasma by gas chromatography and negative chemical ionization mass spectrometry: effects of systemic L-tryptophan administration on brain and blood quinolinic acid concentrations.
    Heyes MP; Markey SP
    Anal Biochem; 1988 Oct; 174(1):349-59. PubMed ID: 2975477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Content of quinolinic acid and of other tryptophan metabolites increases in brain regions of rats used as experimental models of hepatic encephalopathy.
    Moroni F; Lombardi G; Carlà V; Pellegrini D; Carassale GL; Cortesini C
    J Neurochem; 1986 Mar; 46(3):869-74. PubMed ID: 2419500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanism of delayed increases in kynurenine pathway metabolism in damaged brain regions following transient cerebral ischemia.
    Saito K; Nowak TS; Markey SP; Heyes MP
    J Neurochem; 1993 Jan; 60(1):180-92. PubMed ID: 8417138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kynurenine pathway enzymes in brain: responses to ischemic brain injury versus systemic immune activation.
    Saito K; Nowak TS; Suyama K; Quearry BJ; Saito M; Crowley JS; Markey SP; Heyes MP
    J Neurochem; 1993 Dec; 61(6):2061-70. PubMed ID: 8245962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Production of extracellular quinolinic acid in the striatum studied by microdialysis in unanesthetized rats.
    Speciale C; Ungerstedt U; Schwarcz R
    Neurosci Lett; 1989 Oct; 104(3):345-50. PubMed ID: 2530475
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High levels of quinolinic acid in brain of epilepsy-prone E1 mice.
    Nakano K; Takahashi S; Mizobuchi M; Kuroda T; Masuda K; Kitoh J
    Brain Res; 1993 Aug; 619(1-2):195-8. PubMed ID: 8374778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quinolinic acid concentrations in striatal extracellular fluid reach potentially neurotoxic levels following systemic L-tryptophan loading.
    During MJ; Heyes MP; Freese A; Markey SP; Martin JB; Roth RH
    Brain Res; 1989 Jan; 476(2):384-7. PubMed ID: 2522807
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 6-Chloro-D,L-tryptophan, 4-chloro-3-hydroxyanthranilate and dexamethasone attenuate quinolinic acid accumulation in brain and blood following systemic immune activation.
    Saito K; Markey SP; Heyes MP
    Neurosci Lett; 1994 Sep; 178(2):211-5. PubMed ID: 7824198
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The excitotoxin quinolinic acid is present in the brain of several mammals and its cortical content increases during the aging process.
    Moroni F; Lombardi G; Moneti G; Aldinio C
    Neurosci Lett; 1984 Jun; 47(1):51-5. PubMed ID: 6235466
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quinolinate as a Marker for Kynurenine Metabolite Formation and the Unresolved Question of NAD
    Moffett JR; Arun P; Puthillathu N; Vengilote R; Ives JA; Badawy AA; Namboodiri AM
    Front Immunol; 2020; 11():31. PubMed ID: 32153556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased L-tryptophan, 5-hydroxyindoleacetic acid, 3-hydroxykynurenine and quinolinic acid concentrations in cerebral cortex following systemic endotoxin administration.
    Heyes MP; Quearry BJ
    Adv Exp Med Biol; 1991; 294():559-62. PubMed ID: 1722952
    [No Abstract]   [Full Text] [Related]  

  • 16. Decrease in rat cerebral quinolinic acid concentration following chronic hydrocortisone treatment.
    Connick J; Lombardi G; Beni M; Moroni F
    Neurosci Lett; 1988 May; 88(2):216-20. PubMed ID: 2454438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroactive metabolites of L-tryptophan, serotonin and quinolinic acid, in striatal extracellular fluid. Effect of tryptophan loading.
    During MJ; Freese A; Heyes MP; Swartz KJ; Markey SP; Roth RH; Martin JB
    FEBS Lett; 1989 Apr; 247(2):438-44. PubMed ID: 2523822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A mechanism for increased quinolinic acid formation following acute systemic immune stimulation.
    Saito K; Crowley JS; Markey SP; Heyes MP
    J Biol Chem; 1993 Jul; 268(21):15496-503. PubMed ID: 8340378
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neurotoxic actions of quinolinic acid in the central nervous system.
    el-Defrawy SR; Boegman RJ; Jhamandas K; Beninger RJ
    Can J Physiol Pharmacol; 1986 Mar; 64(3):369-75. PubMed ID: 2939936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quinolinic acid formation in immune-activated mice: studies with (m-nitrobenzoyl)-alanine (mNBA) and 3,4-dimethoxy-[-N-4-(-3-nitrophenyl)thiazol-2yl]-benzenesul fonamide (Ro 61-8048), two potent and selective inhibitors of kynurenine hydroxylase.
    Chiarugi A; Moroni F
    Neuropharmacology; 1999 Aug; 38(8):1225-33. PubMed ID: 10462134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.